Total Payments
$14,703
2024 Payments
$1,010
Companies
49
Transactions
587
Medicare Patients
6,640
Medicare Billing
$389,254
Payment Breakdown by Category
Food & Beverage$10,690 (72.7%)
Travel$3,922 (26.7%)
Education$90.27 (0.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,690 | 571 | 72.7% |
| Travel and Lodging | $3,922 | 14 | 26.7% |
| Education | $90.27 | 2 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Penumbra, Inc. | $2,555 | 5 | $0 (2022) |
| Abbott Laboratories | $2,274 | 48 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,423 | 108 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $1,220 | 50 | $0 (2024) |
| Edwards Lifesciences Corporation | $1,149 | 15 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $955.41 | 83 | $0 (2022) |
| Medtronic Vascular, Inc. | $635.41 | 7 | $0 (2020) |
| Amgen Inc. | $511.39 | 29 | $0 (2024) |
| Gilead Sciences, Inc. | $433.19 | 39 | $0 (2018) |
| PFIZER INC. | $379.76 | 28 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,010 | 52 | Novartis Pharmaceuticals Corporation ($266.17) |
| 2023 | $1,036 | 48 | Abbott Laboratories ($438.00) |
| 2022 | $5,178 | 83 | Penumbra, Inc. ($2,555) |
| 2021 | $1,085 | 67 | Janssen Pharmaceuticals, Inc ($253.15) |
| 2020 | $777.47 | 49 | Amgen Inc. ($145.20) |
| 2019 | $3,086 | 101 | Edwards Lifesciences Corporation ($1,080) |
| 2018 | $1,415 | 103 | Gilead Sciences, Inc. ($260.07) |
| 2017 | $1,115 | 84 | Janssen Pharmaceuticals, Inc ($233.37) |
All Payment Transactions
587 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $9.17 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $5.63 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/21/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: Renal Denervation System | ||||||
| 11/18/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: Not Applicable | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/28/2024 | Boston Scientific Corporation | EMBLEM MRI S-ICD (Device) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: EMBLEM_CRM | ||||||
| 10/22/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: Not Applicable | ||||||
| 10/21/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Cardio-renal | ||||||
| 09/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: Cardio-renal | ||||||
| 09/17/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/11/2024 | AngioDynamics, Inc. | ALPHAVAC (Device) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: VIT | ||||||
| 09/05/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/05/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $4.94 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/03/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $21.41 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/27/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.92 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/21/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $27.09 | General |
| Category: Heart Failure | ||||||
| 08/20/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $6.05 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/16/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $29.30 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/16/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $29.07 | General |
| Category: Heart Failure | ||||||
| 07/16/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $6.83 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/10/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $5.04 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,836 | 2,159 | $296,505 | $103,375 |
| 2022 | 20 | 1,166 | 1,392 | $248,767 | $74,454 |
| 2021 | 20 | 1,750 | 2,074 | $384,456 | $102,483 |
| 2020 | 17 | 1,888 | 2,411 | $412,723 | $108,943 |
Total Patients
6,640
Total Services
8,036
Medicare Billing
$389,254
Procedure Codes
84
All Medicare Procedures & Services
84 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 307 | 315 | $53,865 | $15,999 | 29.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 190 | 239 | $41,108 | $13,921 | 33.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 83 | 215 | $29,455 | $13,108 | 44.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 100 | 122 | $29,646 | $11,173 | 37.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 81 | 81 | $25,758 | $9,116 | 35.4% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2023 | 53 | 54 | $24,894 | $8,470 | 34.0% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 13 | 15 | $16,980 | $6,674 | 39.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 55 | 58 | $15,022 | $5,820 | 38.7% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 19 | 20 | $11,340 | $3,647 | 32.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 450 | 532 | $10,640 | $3,244 | 30.5% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 57 | 57 | $9,690 | $3,030 | 31.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 142 | 159 | $5,883 | $1,540 | 26.2% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 16 | 17 | $4,352 | $1,394 | 32.0% |
| 78431 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | Facility | 2023 | 19 | 19 | $3,306 | $1,157 | 35.0% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 13 | 14 | $2,912 | $1,083 | 37.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 11 | 12 | $2,280 | $899.76 | 39.5% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 89 | 90 | $2,880 | $893.66 | 31.0% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 12 | 12 | $2,304 | $768.00 | 33.3% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 41 | 41 | $2,132 | $753.94 | 35.4% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 16 | 17 | $1,003 | $325.72 | 32.5% |
| 93246 | Heart rhythm recording of continous external ekg over 8-15 days | Office | 2023 | 22 | 22 | $572.00 | $176.87 | 30.9% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 21 | 21 | $294.00 | $115.71 | 39.4% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 26 | 27 | $189.00 | $64.26 | 34.0% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2022 | 63 | 68 | $73,908 | $10,449 | 14.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 171 | 203 | $21,435 | $8,372 | 39.1% |
About Dr. Muhammad Ahmad, MD
Dr. Muhammad Ahmad, MD is a Cardiovascular Disease healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1801888953.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Muhammad Ahmad, MD has received a total of $14,703 in payments from pharmaceutical and medical device companies, with $1,010 received in 2024. These payments were reported across 587 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($10,690).
As a Medicare-enrolled provider, Ahmad has provided services to 6,640 Medicare beneficiaries, totaling 8,036 services with total Medicare billing of $389,254. Data is available for 4 years (2020–2023), covering 84 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Lexington, KY
- Active Since 08/16/2005
- Last Updated 03/15/2024
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1801888953
Products in Payments
- Indigo System (Device) $2,555
- ENTRESTO (Drug) $1,078
- XARELTO (Drug) $929.56
- UPTRAVI (Drug) $754.98
- SUPERA (Device) $726.17
- CoreValve Evolut (Device) $620.91
- ELIQUIS (Drug) $474.27
- CARDIOMEMS (Device) $438.53
- OPSUMIT (Drug) $388.65
- LEQVIO (Drug) $345.00
- DRAGONFLY OPSTAR (Device) $282.42
- Corlanor (Drug) $263.35
- Repatha (Biological) $248.04
- LifeVest (Device) $241.92
- BRILINTA (Drug) $168.38
- Peripheral Orbital Atherectomy System (Device) $166.02
- AMPLATZER Occluders (Device) $149.31
- XIENCE SIERRA (Device) $145.74
- MITRACLIP (Device) $142.26
- CardioMEMS HF System (Device) $138.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Lexington
Dr. William Skinner, Md, MD
Cardiovascular Disease — Payments: $463,034
Cardiovascular Disease $463,034
Dr. Steve Lin, Md, MD
Cardiovascular Disease — Payments: $310,565
Cardiovascular Disease $310,565
Dr. Joseph Souza, M.d, M.D
Cardiovascular Disease — Payments: $238,102
Cardiovascular Disease $238,102
Gery Tomassoni, M.d, M.D
Cardiovascular Disease — Payments: $215,300
Cardiovascular Disease $215,300
Armaghan Soomro, Md, MD
Cardiovascular Disease — Payments: $114,497
Cardiovascular Disease $114,497
Dr. Adrian Messerli, Md, MD
Cardiovascular Disease — Payments: $67,777
Cardiovascular Disease $67,777